R. Gervais
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Molecular Biology
- Cancer Research
- Epidemiology
- Co-authors
- Fabrice BarlésiG. RobinetH. LénaC. ChouaïdI. MonnetD. PaillotinAbdesslam ChajaraJ. Hureaux
- Topics
- Lung Cancer Treatments and Mutations (38 papers)Lung Cancer Research Studies (26 papers)Lung Cancer Diagnosis and Treatment (19 papers)
- Journals
- Journal of Clinical OncologyInternational Journal of Radiation Oncology*Biology*PhysicsAnnals of Oncology
- Partner nations
- FranceLuxembourgUnited Kingdom
In The Last Decade
R. Gervais
70 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Pulmonary and Respiratory Medicine 963
- Oncology 903
- Molecular Biology 185
- Cancer Research 114
- Epidemiology 74
Countries citing papers authored by R. Gervais
This map shows the geographic impact of R. Gervais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Gervais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Gervais more than expected).
Fields of papers citing papers by R. Gervais
This network shows the impact of papers produced by R. Gervais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Gervais. The network helps show where R. Gervais may publish in the future.
Co-authorship network of co-authors of R. Gervais
This figure shows the co-authorship network connecting the top 25 collaborators of R. Gervais. A scholar is included among the top collaborators of R. Gervais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Gervais. R. Gervais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 18 | |
| 3 | 40 | |
| 4 | 6 | |
| 5 | 5 | |
| 6 | 15 | |
| 7 | 1 | |
| 8 | 11 | |
| 9 | 11 | |
| 10 | 7 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 15 | |
| 14 | 129 | |
| 15 | 1 | |
| 16 | 181 | |
| 17 | Safety and pharmacokinetics of first-line amg 479 (mab to igf1r) or amg 102 (mab to hgf/sf) with platinum-based chemotherapy in extensive-stage small cell lung cancer (sclc) | 6 |
| 18 | 18 | |
| 19 | 101 | |
| 20 | 104 |
About R. Gervais
R. Gervais is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiological and Ultrasound Technology, having authored 75 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Research Studies (26 papers) and Lung Cancer Diagnosis and Treatment (19 papers). The work is most often cited by research in Oncology (903 citations), Pulmonary and Respiratory Medicine (963 citations) and Cancer Research (114 citations). R. Gervais has collaborated with scholars based in France, Luxembourg and United Kingdom. Frequent co-authors include Fabrice Barlési, G. Robinet, H. Léna, C. Chouaïd, I. Monnet, D. Paillotin, Abdesslam Chajara, J. Hureaux, S. Bota and H. Bérard. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.